Mark A. Goldsmith - 15 Apr 2026 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Reporting relationship: President and Chief Executive Officer, Director
Issuer ticker: RVMD
Reported as of: 15 Apr 2026
Net transaction value: -$18,010,488
SEC form: 4
Accepted by SEC: 17 Apr 2026, 19:26:28 UTC
Prior SEC filing: 19 Mar 2026
Next SEC filing: 18 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Jack Anders, as attorney-in fact for Mark A. Goldsmith

Key filing fact

Mark A. Goldsmith filed Form 4 for Revolution Medicines, Inc. (RVMD) on 17 Apr 2026.

Key facts

This page summarizes Mark A. Goldsmith's Form 4 filing for Revolution Medicines, Inc. (RVMD).
5 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 17 Apr 2026, 19:26.

Change

Previous filing in this sequence was filed on 19 Mar 2026.
Current net transaction value: -$18,010,488.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001246842 Primary reporting owner

GOLDSMITH MARK A

Relationship: President and Chief Executive Officer, Director
Address: C/O REVOLUTION MEDICINES, INC., 700 SAGINAW DRIVE, REDWOOD CITY
Signature: /s/ Jack Anders, as attorney-in fact for Mark A. Goldsmith
Signature date: 17 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RVMD transaction

Common Stock

Options Exercise

Transaction value
Shares: +23,244
Change %: +8.4%
Price: $4.09^*
Shares after: 299,942
Date: 15 Apr 2026
Ownership: Direct
Footnotes: F1, F2

RVMD transaction

Common Stock

Options Exercise

Transaction value
Shares: +96,756
Change %: +32%
Price: $4.73^*
Shares after: 396,698
Date: 15 Apr 2026
Ownership: Direct
Footnotes: F1, F2

RVMD transaction

Common Stock

Sale

Transaction value: $18,010,488
Shares: -120,000
Change %: -30%
Price: $150.09
Shares after: 276,698
Date: 15 Apr 2026
Ownership: Direct
Footnotes: F1, F2, F3

RVMD holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 594,060
Date: 15 Apr 2026
Ownership: Trust
Footnotes: F4

RVMD holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 64,424
Date: 15 Apr 2026
Ownership: Trust
Footnotes: F5

RVMD holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 64,424
Date: 15 Apr 2026
Ownership: Trust
Footnotes: F6

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RVMD transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -23,244
Change %: -49%
Price: $0.000000^*
Shares after: 24,464
Date: 15 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 23,244
Exercise price: $4.09
Footnotes: F1

RVMD transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -96,756
Change %: -19%
Price: $0.000000^*
Shares after: 424,085
Date: 15 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 96,756
Exercise price: $4.73
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 6 footnotes

Footnote F1

Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024.

Footnote F2

Includes 201,150 restricted stock units.

Footnote F3

This transaction was executed in multiple trades at prices ranging from $150.00 to $150.64. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F4

Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.

Footnote F5

Held by Jonathan Goldsmith Revocable Trust.

Footnote F6

Held by Rebecca Goldsmith Revocable Trust.

SEC remarks

President and Chief Executive Officer